Long-Lasting T Cell Responses in BNT162b2 COVID-19 mRNA Vaccinees and COVID-19 Convalescent Patients

Long-Lasting T Cell Responses in BNT162b2 COVID-19 mRNA Vaccinees and COVID-19 Convalescent Patients

The emergence of novel variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has made it more difficult to prevent the virus from spreading despite available vaccines. Reports of breakthrough infections and decreased capacity of antibodies to neutralize variants raise the ques...

Full description

Bibliographic Details
Main Authors: Antti Hurme, Pinja Jalkanen, Jemna Heroum, Oona Liedes, Saimi Vara, Merit Melin, Johanna Teräsjärvi, Qiushui He, Sakari Pöysti, Arno Hänninen, Jarmo Oksi, Tytti Vuorinen, Anu Kantele, Paula A. Tähtinen, Lauri Ivaska, Laura Kakkola, Johanna Lempainen, Ilkka Julkunen
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Immunology
Subjects:
Covid-19
BNT162b2
vaccine
T cell mediated immunity
humoral immunity
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.869990/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.869990/full

Similar Items